open access

Vol 72, No 1-2 (2004)
ORIGINAL PAPERS
Published online: 2008-02-18
Submitted: 2013-02-22
Get Citation

Antieosinophil action of IL-12 in human polyp culture

Andrzej M. Fal, Jerzy Rabczyński, Agnieszka Gerber, Wojciech Mikulewicz, Wojciech Barg, Andrzej Obojski
Pneumonol Alergol Pol 2004;72(1-2):14-18.

open access

Vol 72, No 1-2 (2004)
ORIGINAL PAPERS
Published online: 2008-02-18
Submitted: 2013-02-22

Abstract

Rationale: Tissue eosinophilia is an important pathophysiological issue in bronchial ashma and nasal polyps. Its magnitude is regulated by several mechanisms, including selective migration of eossinophils to peripheral tissues and prolongation of survival. A key role in this processes is assigned to Th2 originating cytokines: IL-3, IL-5, GM-CSF. It has been previously demonstrated that IL-12 diminishes tissue eosinophilia in an animal model, and Hofstra showed that Il-12 together with IL-18 prevents allergen-induced increase bronchial hyperresponsiveness, BAL eosinophilia and the development of allergen-specific Th2 cells.
Methods: Nasal polyps were obtained during routine surgery and were cultured in fragments of approximately 30 mg for 2, 6, and 15 days in RPMI 1640 in the absence or presence of IL-12. Afterwards a dose-dependency was tested at day 2 of culture. Polyp tissue from cultures was than processed to slides, stained with Giemsa and cells were counted in light microscopy (400x).
Results: Eosinophils represented 62,8 &plusmn; 21,3% of residing cells in nasal polyps at the day 0. IL-12 (1 &#956;g/ml) caused a significant time-dependent decrease in the percentage of Eos after 2 and 6 days. The effect of IL-12 at day 2 was concentration-dependent: control, 28,2 &plusmn; 2,9; at 10 ng/ml, 13,9 &plusmn; 6,4 (n = 4, p < 0,05); at 100 ng/ml, 11,6 &plusmn; 2,1 (p < 0.01); at 1 &#956;g/ml, 7,5 &plusmn; 1,5 (p < 0,005).
Conclusion: IL-12 acts as potent topical antieosinophilic agent. Its action can be seen in a cultured polyp environment. It is visible already after two days and is concentration-dependent. Further study is needed to elucidate tissue mechanisms of this action.

Abstract

Rationale: Tissue eosinophilia is an important pathophysiological issue in bronchial ashma and nasal polyps. Its magnitude is regulated by several mechanisms, including selective migration of eossinophils to peripheral tissues and prolongation of survival. A key role in this processes is assigned to Th2 originating cytokines: IL-3, IL-5, GM-CSF. It has been previously demonstrated that IL-12 diminishes tissue eosinophilia in an animal model, and Hofstra showed that Il-12 together with IL-18 prevents allergen-induced increase bronchial hyperresponsiveness, BAL eosinophilia and the development of allergen-specific Th2 cells.
Methods: Nasal polyps were obtained during routine surgery and were cultured in fragments of approximately 30 mg for 2, 6, and 15 days in RPMI 1640 in the absence or presence of IL-12. Afterwards a dose-dependency was tested at day 2 of culture. Polyp tissue from cultures was than processed to slides, stained with Giemsa and cells were counted in light microscopy (400x).
Results: Eosinophils represented 62,8 &plusmn; 21,3% of residing cells in nasal polyps at the day 0. IL-12 (1 &#956;g/ml) caused a significant time-dependent decrease in the percentage of Eos after 2 and 6 days. The effect of IL-12 at day 2 was concentration-dependent: control, 28,2 &plusmn; 2,9; at 10 ng/ml, 13,9 &plusmn; 6,4 (n = 4, p < 0,05); at 100 ng/ml, 11,6 &plusmn; 2,1 (p < 0.01); at 1 &#956;g/ml, 7,5 &plusmn; 1,5 (p < 0,005).
Conclusion: IL-12 acts as potent topical antieosinophilic agent. Its action can be seen in a cultured polyp environment. It is visible already after two days and is concentration-dependent. Further study is needed to elucidate tissue mechanisms of this action.
Get Citation

Keywords

eosinophil; interleukin 12; asthma; nasal polyps

About this article
Title

Antieosinophil action of IL-12 in human polyp culture

Journal

Advances in Respiratory Medicine

Issue

Vol 72, No 1-2 (2004)

Pages

14-18

Published online

2008-02-18

Bibliographic record

Pneumonol Alergol Pol 2004;72(1-2):14-18.

Keywords

eosinophil
interleukin 12
asthma
nasal polyps

Authors

Andrzej M. Fal
Jerzy Rabczyński
Agnieszka Gerber
Wojciech Mikulewicz
Wojciech Barg
Andrzej Obojski

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl